KineRuby

Research

HomeUNH overviewFinancial chartsStock screener

Valuation & planning

DCF valuationCompound interestDividend snowballAll tools

Watchlist

Star a ticker to pin it here.

KineRubyLog in
HomeAnalysisScreenerTools
UnitedHealth Group Incorporated logo

UnitedHealth Group Incorporated

UNHNYSE

$423.71

Last price · USD

Market cap
$385.6B
P/E
32.0x
EV / EBITDA
19.1x
P/S
0.9x
FCF yield
4.2%
Div. yield
2.05%

Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.

OverviewBusinessFinancialsPeersChartsValuation

UnitedHealth Group Incorporated cash flow statement

Annual · USD millions except per-share data · 38 lines

Fiscal yearTrend2025latest2024202320222021CAGR
Operating activities
Net income12,80715,24222,38120,12017,285-7.2%
Depreciation & amortization4,3614,0993,9723,4003,103+8.9%
Deferred income tax(989)(296)(245)(673)(814)—
Stock-based compensation9711,0181,059925800+5.0%
Change in working capital2,282(808)1,6432,2461,522+10.7%
Accounts receivables0(1,437)(3,114)(2,523)(1,000)—
Inventory001,0380(1,031)—
Accounts payables02,4633,5161,9643,863—
Other working capital2,282(1,834)2032,805(310)—
Other non-cash items2654,949258188447-12.3%
Net cash from operating activities19,69724,20429,06826,20622,343-3.1%
Operating cash flow19,69724,20429,06826,20622,343-3.1%
Investing activities
Investments in PP&E(3,622)(3,499)(3,386)(2,802)(2,454)—
Capital expenditure(3,622)(3,499)(3,386)(2,802)(2,454)—
Acquisitions, net(4,509)(13,408)(10,136)(21,458)(4,821)—
Purchases of investments0(27,308)(18,314)(18,825)(1,843)—
Sales / maturities of investments36127,83316,53711,98815,296-60.8%
Other investing activities(915)(4,145)(275)2,621(16,550)—
Net cash from investing activities(8,685)(20,527)(15,574)(28,476)(10,372)—
Financing activities
Net debt issuance72614,6604,28012,5362,481-26.5%
Short-term net debt issuance726(151)11732(1,302)—
Long-term net debt issuance014,8114,26911,8043,783—
Net stock issuance(5,545)(7,154)(6,647)(5,747)(5,000)—
Common stock issuance01,8461,3531,2531,355—
Common stock repurchased(5,545)(9,000)(8,000)(7,000)(5,000)—
Net common stock issuance(5,545)(7,154)(6,647)(5,747)(3,645)—
Common dividends paid(7,916)(7,533)(6,761)(5,991)(5,280)—
Net dividends paid(7,916)(7,533)(6,761)(5,991)(5,280)—
Net preferred stock issuance0000(1,355)—
Other financing activities1,091(3,485)(2,401)3,428344+33.4%
Net cash from financing activities(11,644)(3,512)(11,529)4,226(7,455)—
Cash summary
Effect of forex changes on cash3,441(280)9734(62)—
Net change in cash2,809(115)2,0621,9904,454-10.9%
Cash at beginning of period25,31225,42723,36521,37516,921+10.6%
Cash at end of period28,12125,31225,42723,36521,375+7.1%
Free cash flow16,07520,70525,68223,40419,889-5.2%
Income taxes paid04,6206,0785,2223,966—
Interest paid03,5943,0351,9451,653—